Dual Diagnosis & Co-Occurring Mental Health Treatment in New Jersey

What 'dual diagnosis' means

Dual diagnosis, more formally called co-occurring disorders, refers to having both a substance use disorder and a mental health condition — depression, anxiety, PTSD, bipolar disorder, and others — at the same time. This is common enough that SAMHSA maintains dedicated guidance on it, framing co-occurring conditions as something treatment systems need to plan for rather than treat as an unusual exception.

The two conditions often interact. Someone might use a substance to manage symptoms of an untreated mental health condition, or heavy substance use might trigger or worsen psychiatric symptoms. Because of that interaction, treating only one side of the picture — only the substance use, or only the mental health diagnosis — tends to leave the other side unaddressed and can undermine progress on both.

Why integrated treatment matters

SAMHSA's evidence-based practice materials on co-occurring disorders describe integrated treatment — where substance use and mental health care are coordinated, often by the same team, rather than delivered through separate, disconnected providers — as generally producing better outcomes than sequential or parallel but uncoordinated care.

In practice, integration can mean a lot of things: a shared treatment plan, a psychiatric prescriber who communicates directly with a substance use counselor, or a single clinical team handling both. It can also just be a phrase on a website with no real coordination behind it. The only way to know which one you're looking at is to ask specific, practical questions rather than accept the label 'dual diagnosis program' at face value.

The alternative to integrated care is sometimes called sequential or parallel treatment: addressing the substance use disorder first and the mental health condition later, or treating both at once through entirely separate providers who do not communicate. That model is not necessarily unworkable, but it puts more of the coordination burden on the patient and family, which is worth knowing going in.

What to ask about psychiatric staffing

Because mental health conditions often require medication management, ongoing psychiatric evaluation, or specialized therapy approaches (like trauma-focused therapy for PTSD), the staffing behind a program's mental health side matters as much as its substance use staffing.

• Is there a psychiatrist, psychiatric nurse practitioner, or other prescriber on staff, and how often do patients actually see them?
• How are psychiatric medications coordinated with any substance use disorder medications someone might be taking — ask a prescriber for specifics rather than expecting a general answer here.
• Does the program have licensed mental health clinicians, or does it only offer general substance use counseling with a light mental health component?
• What happens if someone's mental health symptoms are more acute than the program is equipped to manage — is there a plan for referral to a higher level of psychiatric care?

What to ask about coordination between teams

Even a program with good staff in both areas can fail at coordination if the two sides don't actually talk to each other. This is worth probing specifically, since it's the part most likely to be glossed over.

• Do the mental health and substance use teams meet regularly to discuss shared patients, or work independently?
• Is there one point person coordinating a patient's overall care plan across both areas?
• How is information shared between a psychiatric prescriber and a substance use counselor day to day?
• If someone is already seeing an outside psychiatrist or therapist, how does the program coordinate with that existing provider rather than starting over?

A note on assessment and diagnosis

Determining whether someone has a co-occurring mental health condition — and which one — requires a clinical assessment by a qualified professional. This page can describe the concept and the questions worth asking, but it can't and shouldn't attempt to evaluate anyone's individual symptoms. If you're unsure whether what you or someone you care about is experiencing qualifies as a co-occurring condition, that's a good first question to bring to an intake assessment or a primary care provider.

It also helps to know that a co-occurring diagnosis is not always made before treatment starts. Sometimes a mental health condition becomes clearer once someone is no longer actively using a substance, since withdrawal, intoxication, and long-term use can all produce symptoms that resemble anxiety, depression, or mood instability. A program that builds in ongoing psychiatric reassessment during treatment, rather than relying on a single intake screening, is generally better positioned to catch this.

Where this organization fits in

Princeton Detox Support Group is an independent information and referral line — not a treatment provider, clinic, or diagnostic service, and not able to evaluate anyone's mental health or substance use status directly. What the line can do is help someone think through what to ask a program about how it handles co-occurring care, and point toward independent, verifiable resources for finding programs that describe integrated treatment. Any program's specific staffing and coordination claims should be confirmed directly, and insurance questions should always go to the plan and the program in writing.